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Abstract
Background: Health risk appraisal is a promising method for health promotion and prevention in older persons. The Health Risk
Appraisal for the Elderly (HRA-E) developed in the U.S. has unique features but has not been tested outside the United States.
Methods: Based on the original HRA-E, we developed a scientifically updated and regionally adapted multilingual Health Risk
Appraisal for Older Persons (HRA-O) instrument consisting of a self-administered questionnaire and software-generated feed-back
reports. We evaluated the practicability and performance of the questionnaire in non-disabled community-dwelling older persons
in London (U.K.) (N = 1090), Hamburg (Germany) (N = 804), and Solothurn (Switzerland) (N = 748) in a sub-sample of an
international randomised controlled study.
Results: Over eighty percent of invited older persons returned the self-administered HRA-O questionnaire. Fair or poor self-
perceived health status and older age were correlated with higher rates of non-return of the questionnaire. Older participants and
those with lower educational levels reported more difficulty in completing the HRA-O questionnaire as compared to younger and
higher educated persons. However, even among older participants and those with low educational level, more than 80% rated the
questionnaire as easy to complete. Prevalence rates of risks for functional decline or problems were between 2% and 91% for the
19 HRA-O domains. Participants' intention to change health behaviour suggested that for some risk factors participants were in a
pre-contemplation phase, having no short- or medium-term plans for change. Many participants perceived their health behaviour
or preventative care uptake as optimal, despite indications of deficits according to the HRA-O based evaluation.
Conclusion: The HRA-O questionnaire was highly accepted by a broad range of community-dwelling non-disabled persons. It
identified a high number of risks and problems, and provided information on participants' intention to change health behaviour.
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Background
There is a growing interest in health risk appraisal (HRA)
for use in older persons. HRA instruments typically con-
sist of a questionnaire and an algorithm for generating
feedback reports to participants and health care providers.
Controlled studies support that HRA combined with sup-
plemental counselling by a physician, health educator, or
other health professional is a potentially cost-effective
method of health promotion and prevention for older
persons [1]. Providers, organisations or researchers inter-
ested in a HRA can now choose among multiple HRA
instruments that have been developed for use in older per-
sons [1].
There are multiple differences between available HRA
instruments for use in older persons. The HRA-E (HRA for
the Elderly) questionnaire developed by a University of
California faculty group has several distinguishing fea-
tures [1,2]: (1) its main purpose is to identify risk factors
for functional decline; this contrasts with other HRA
instruments which focus on risk factors for mortality or
address selected health behaviour and preventative care
issues alone; (2) unlike other HRA instruments, it is based
on scientific evidence for the selection of risk factor
domains and instruments to measure these domains, and
for the definition of the recommendations in the feedback
[1]; (3) unlike most other HRA questionnaires for older
persons (with the exception of the YOU FIRST Senior
Health Assessment [1]), it identifies intention and barriers
to changing health behaviours which can be used to
enhance tailoring of participant feed-back ; and (4) it
includes a computerised algorithm to generate feed-back
to both older persons and general practitioners or other
health professionals (see Figure 1), in contrast with con-
ventional HRA instruments which do not specifically
address primary care practitioners.
However, despite these advantages, there are factors limit-
ing the use of the HRA-E in Europe: first it had not been
developed for use in a multilingual environment, second
its feasibility and performance had not been tested out-
side the North American environment, and third, the
HRA-E is outdated because new scientific evidence has
accumulated since its development in 1997.
We decided to revise and update the original HRA-E and
to name this new version "Health Risk Appraisal for Older
Persons" (HRA-O) [3]. The stepwise development from
HRA-E to HRA-O instrument versions 1 to 4 is described
in the following paragraphs, and depicted in Figure 2.
Development and testing of HRA-E
The original HRA-E was used as a basis for the subsequent
development of HRA-O versions. After a multi-step devel-
opment process including a systematic literature review,
expert input, as well as multiple focus group and pilot
testing activities, a first version of the HRA-E was devel-
oped. It consisted of a self-administered questionnaire
(for the 17 included domains, see Table 1), a software pro-
gram for generating an individualised feed-back report to
the older participant and a summary report for the health
care professional [2]. This first version was tested in three
samples of older Americans: (1) a large medical group
practice with links to Health Maintenance Organization
(HMO) plans, (2) a national sample of American Associ-
ation of Retired Persons (AARP) members, and (3) a sen-
ior centre (total N = 1924) [2]. A second version of the
HRA-E was generated based on this experience.
Scientific update of HRA-E
The first step involved a scientific update of the HRA-E.
First, based on a systematic literature search on risk factors
for functional status decline in older persons [4], potential
new domains for inclusion in the updated questionnaire
were identified. This review was presented to an interna-
tional Expert Panel (from Denmark, Germany, Nether-
lands, Switzerland, U.K., USA) in the fields of
epidemiology, geriatrics, sociology and nursing. We used
a consensus panel process adapted to a multilingual
group of experts. They evaluated new potential domains
based on the four criteria listed below, which had previ-
ously been used for the development of the original HRA-
E instrument:
(1) magnitude of effect and potential impact on func-
tional impairment;
(2) validity and generalisability of results;
(3) potential for risk reduction;
(4) feasibility of assessment.
In a second step, the same Expert Panel selected instru-
ments to measure new potential domains, and decided
whether existing instruments in the original HRA-E ques-
tionnaire had to be replaced. A list of instruments to be
considered was developed for each domain of the
updated questionnaire, in conjunction with information
from the current literature informing the experts about the
validity and reliability of each instrument for use in com-
munity-dwelling older people. The following criteria for
selecting the instruments or evaluating the inclusion of
existing instruments were used:
(1) reliability;
(2) validity;
(3) feasibility; andBMC Medical Research Methodology 2007, 7:1 http://www.biomedcentral.com/1471-2288/7/1
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(4) use of the instrument in other large databases of older
persons.
Development of HRA-O version 1 (HRA-O-1)
Based on recommendations of the Expert Panel, specific
questionnaires for two domains (on fruit/fibre intake and
vision function, details in Table 1) were added to the new
HRA-O-1 questionnaire. In addition, selected improve-
ments were made for individual questionnaire items and
recommendations in the feed-back statements.
In a next step, the questionnaire and text for the partici-
pant and provider feed-back reports were translated into
the German language by a professional translator, and
then translated back to the English language by a second
translator who was blinded to the original version. The
back-translation was compared with the original version,
and discrepancies were resolved by a third independent
translator. Based on this version intended for use in Ger-
many, we developed a Switzerland German version by
adapting language and grammar. Also, based on the
American English version, a separate English version for
use in the U.K. was developed, following changes to the
language, grammar and style. These translations required
a redesign of the original HRA-E to accommodate multi-
ple language versions. This involved a revision of the
questionnaire data entry system and of the software sys-
tem generating the feed-back reports. The newly generated
HRA-O-version-1 (HRA-O-1) was alpha tested by evaluat-
ing the functionality and content of data entry and report
generation.
Based on this HRA-O-1, focus group meetings with older
persons and general practitioners, and pilot tests in small
groups of older persons in Switzerland, Germany, and the
U.K., were conducted. The questionnaire was then region-
ally adapted without changing the content of the ques-
tions. For example, units for reporting weight (e.g., stones,
Common components of Health Risk Appraisal for the Elderly (HRA-E) and of all versions of the Health Risk Appraisal for  Older Persons (HRA-O) Figure 1
Common components of Health Risk Appraisal for the Elderly (HRA-E) and of all versions of the Health Risk Appraisal for 
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kilograms) or examples of food items with a high fat con-
tent (e.g. hot dogs in U.K., and "Bratwurst" in Switzer-
land) were added as needed. The feed-back statements for
the four language versions (American English, U.K. Eng-
lish, Germany German, and Switzerland German) were
adapted to incorporate regional variations including
postal addresses, referrals to health providers, and access
or payment for preventative care services.
Testing of HRA-O-1
A field test in 26 community-dwelling older persons in
the US evaluated the functionality and acceptance of
HRA-O-1. In addition, we also conducted a study for eval-
uating the reliability of instruments included in the HRA-
O-1 questionnaire (Table 1) in three samples of commu-
nity-dwelling persons aged 75 years and older in Ham-
burg (Germany) (N = 51), Ulm (Germany) (N = 51) and
Bern (Switzerland) (N = 48) [5]. In a first sub-sample of
100 persons, the test-retest reliability of individual ques-
tionnaires included in HRA-O-1 (Table 1) and of specific
questionnaires on oral health and pain (two domains that
we considered adding to the HRA-O-1 based on the Expert
Panel recommendations) [6]. Test-retest reliability was
good to excellent, as measured by Cohen's Kappa (0.64 ≤
κ ≤ 0.89) [7], with the following exceptions. For three
domains (pain, preventative care, and falls), Cohen's
Kappa was <0.6. In a different sub-sample of 50 persons,
the validity of the specific questionnaires included in the
HRA-O-1 questionnaire was determined by comparing
self-administered with interviewer-administered answers
to the questionnaires [7]. Cohen's Kappa revealed good to
excellent validity in most domains with values ranging
between 0.69 and 1.0. Values were below 0.69 for ques-
tionnaires assessing physical activity, oral health, and
basic activities of daily living. Low Kappa values could be
explained by suboptimal presentation of the questions in
Development stages from the Health Risk Appraisal for the Elderly (HRA-E) to the Health Risk Appraisal for Older Persons  version 4 (HRA-O) Figure 2
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Table 1: Sources of Health Risk Appraisal for the Elderly (HRA-E) and Health Risk Appraisal for Older Persons (HRA-O) 
questionnaire
Domain Definition of problem risk Description of questions (questionnaire item source)
Accident prevention Driving without using seat belt Use of seatbelt [26]
Alcohol use Possible hazardous alcohol use (based on age- and 
gender-specific limits of quantity and frequency of self-
reported alcohol use)
The WHO Alcohol Use Disorders Identification Test [15]
Falls History of repeated falls in previous 12 months Study of Osteoporotic Fractures Research Group Survey [20]
Self-reported limitation of activities due to fear of 
falling
Fear of falling [32]
Functional status Difficulty/need for human assistance in ≥1 BADL item Basic activities of daily living (BADL) [19]
Difficulty/need for human assistance in ≥2 IADL items Instrumental activities of daily living (IADL) [22]
Changed kind of activity Preclinical mobility disability [13]*
Decreased frequency of activity
Health status Moderate or fair self-perceived health status Self-perceived health status [18]
Hearing Impaired hearing Hearing Handicap Inventory for the Elderly [23]
No hearing check-up in previous year History of hearing examination [33]
Incontinence Urinary incontinence on > 5 days during the last year Urinary incontinence (Medical, Epidemiological and Social Aspects 
of Aging Project Questionnaire) [17]
Medication use Use of ≥4 medications Use of medications [2]
Use of long-acting benzodiazepine or amitriptyline Inappropriate medication use [14] *
Medication side effect Medication side effects [35]
Difficulties with medication compliance Medication compliance [2]
Medical History Presence of chronic condition(s) Chronic conditions [18]
Memory Memory problems Memory Self Report [28]
Mood Depressive mood 5-item Mental Health Inventory Screening Test [29]
Nutrition Consumption of >2 high fat food items per day Cholesterol Reduction in Seniors Program Fat Food Screening
Questionnaire [31]
Consumption of < 5 fruit/fibre items per day Cholesterol Reduction in Seniors Program Plant Food Screening
Questionnaire [31]*
Motivation for change in fat intake/fruit intake Transtheoretical model of behaviour change [2, 21,27]
Body mass index <20 or ≥27; loss of weight Self-reported height and weight (body mass index), weight change
Oral Health* Oral health problem Geriatric oral health assessment index [11]*
No dental check in previous year History of dental care [33]
Pain* Presence of moderate to severe pain Geriatric Pain Measure [12]*
Physical activity Less than 5 times/week moderate or strenuous 
activity
Physical Activity Scale for the Elderly [34]
Motivation for behaviour change Transtheoretical model of behaviour change [2,21,27]
Preventative care No blood pressure control in previous year History of blood pressure measurement [33]
Elevated self-reported blood pressure Self-reported blood pressure
No mammography in previous 2 years History of breast cancer screening [33]
No cervical smear in previous 3 years History of cervical smear [33]
No cholesterol measurement in previous 5 years History of cholesterol measurement [33]
Elevated self-reported cholesterol Self-reported cholesterol level
No faecal occult blood test in previous year History of colon cancer screening [33]
No blood glucose measurement in previous 3 years History of diabetes screening [33]
No influenza vaccination in previous year History of influenza immunisation [33]
No pneumococcal vaccination (ever) History of pneumococcal immunisation [33]
Social factors Low level of emotional support Medical Outcomes Study Social Support Survey [29]
High risk of social isolation Lubben Social Network Scale [24]
Marginal family ties Subscale Lubben Social Network Scale [24]
Marginal friendship ties Lubben Social Network Scale [24]
No participation in groups Single-item question [16]
Tobacco use Current tobacco use Tobacco use (Partners in Prevention Tobacco Use Questionnaire) 
[2]
Motivation for behaviour change Transtheoretical model of behaviour change [2,21,27]
Vision Problem in ≥ 1 vision sub-domain Visual Functioning Questionnaire [25]*
No vision check-up in previous year History of vision examination [33]
In addition, the questionnaire includes socio-demographics survey items (age, gender, education, professional activity, living arrangement) and a 
survey for participant feed-back to the questionnaire. Items marked with an asterisk (*) were added to the HRA-O questionnaires and are NOT 
included in the HRA-E.BMC Medical Research Methodology 2007, 7:1 http://www.biomedcentral.com/1471-2288/7/1
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the self-administered questionnaire, and consequently,
introductory statements, wording of these questions and
graphical presentation of items were improved.
Testing of HRA-O-version-2 (HRA-O-2)
Based on the testing of HRA-O-1, a revised version HRA-
O-2 was developed. The feasibility of this updated version
was then tested in three selected samples of persons aged
65 years and older in three European countries (U.K.:
urban-based general practitioner lists in London, N = 348;
Germany: occupants of sheltered housing facilities in
Hamburg, N = 149; Switzerland: community-based lists
in rural/suburban area in the Cantons of Solothurn and
Bern, N = 213) [8]. The majority of people judged the
questionnaire as easy to comprehend (U.K., 81.4%; Ger-
many, 93.1%; Switzerland, 97.2%) and to complete
(83.2%, 91.4%, and 95.8%, respectively). Feed-back from
older persons to the participant reports was systematically
evaluated [9].
We decided to further test the validity of self-reported
information on preventative care use captured by HRA-O-
2. For this purpose, in the Swiss sub-sample (N = 213),
self-reported data of preventative care were compared
with medical record based information obtained from
general practitioners. Agreement between the two data
sources was good to excellent with agreement rates eighty
percent or more for the comparison between self-reported
and record-based information for the individual measures
of preventative care [10].
Development of HRA-O-version-3 (HRA-O-3)
Based on the original recommendations of the Expert
Panel, two new domains were added to the revised HRA-
O-3 and measured using the following tools: (1) oral
health: the Geriatric Oral Health Assessment Index
(GOHAI) was added to assess the impact of oral condi-
tions on physical and psychosocial functions [11] and (2)
pain: the multidimensional Geriatric Pain Measure was
selected to evaluate the experience and intensity of pain,
the impact of pain on function and on social network
[12]. Instruments were updated for two domains already
included in previous HRA-O versions: (1) inappropriate
medication use: we added questions on inappropriate
medications, and selected from drugs with potentially
severe side effects, the two categories that had the highest
prevalence of use in a community-based sample of older
persons [13]; (2) preclinical functional decline: a measure
of preclinical functional decline was added to identify
people early in the trajectory of functional status decline
[14]. In addition, information contained in the feed-back
reports was updated.
Testing of HRA-O-3
In order to test the functionality and feasibility of the
updated HRA-O-3, a field test of the American English ver-
sion was conducted in conjunction with the Center for
Healthy Aging in Santa Monica, CA, U.S.A. Overall, 84
community-dwelling older persons completed the new
HRA-O-3 questionnaires, received feed-back reports, and
were asked to provide feed-back on the HRA-O-3. Results
confirmed functionality and acceptability, and only min-
imal remaining areas of improvement were found at this
stage. Furthermore persons who recalled the earlier field
tests with the original HRA-E instrument confirmed that
updates had resulted in improvement related to ease of
administration and completeness of contents.
Development and description of HRA-O-version-4 (HRA-
O-4)
Translations and back-translations of newly added com-
ponents, as well as regional adaptations were made. Based
on the testing of HRA-O-3 in the U.S. setting, necessary
revisions and adaptations were implemented. As a result,
HRA-O-4 was produced in an American English, U.K. Eng-
lish, Germany German, and Switzerland German version
(for components, see Figure 1). The U.K. English version
of this version 4 of HRA-O questionnaire is enclosed [see
Additional file 1]. The 19 domains included in the HRA-
O-4 questionnaire are listed in Table 1[11-35].
The generation of feed-back reports to older participants
and health care providers is based on a computerised sys-
tem, including a screen-guided system for manual data
entry, and an automated analysis of the entered data.
From the entered data, a software system generates sum-
mary or risk scores and corresponding detailed written
feed-back on identified risks to the older person. The
report summarises the suspected problem (while always
emphasising that this information is based on self-report)
and generates feedback by selecting and arranging words
and sentences from more than 1000 possible feedback
algorithms. Feed-back reports were developed using cur-
rent scientific evidence related to health promotion, risk
factor modification, and problem management. The sum-
mary feed-back report to the health care provider is
arranged in the format of a check-list on one double sided
page. The older person's report (approximately 32 pages)
is personalised and contains both general information on
each domain as well as individualised specific recommen-
dations derived from the questionnaire analysis. Cross-
links were made between domains, for example by taking
into account level of physical activity and body mass
index when giving recommendations to an older person
reporting high blood pressure management. Participants'
intention to change health behaviour or self reported rea-
sons for not changing behaviour was taken into account.BMC Medical Research Methodology 2007, 7:1 http://www.biomedcentral.com/1471-2288/7/1
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In addition, feed-back reports to older participants also
included sources of additional information.
Goals of this study
The goal of this paper is to evaluate the feasibility and per-
formance of the newly developed HRA-O questionnaire
with base-line data from an international randomised
study, the PRO-AGE study (PRevention in Older people –
Assessment in GEneralists' practices) [3]. To evaluate its
feasibility, we analysed response rates and feed-back from
older persons, including subgroups of older persons in
whom use of a self-administered questionnaire is often
queried: those with a low level of education and the very
old. To evaluate the performance of the HRA-O question-
naire, we determined prevalence rates of identified risks
and problems and participants' intention to change
health behaviour as well as self-perceived barriers to
change.
Methods
Study participants
Data presented in this paper are from a randomised con-
trolled study, the PRO-AGE study (London, U.K.; Ham-
burg, Germany; and Solothurn, Switzerland). In this
study, non-disabled community-dwelling older persons
were recruited from primary care and randomised to inter-
vention and control groups [3]. After randomisation, all
subjects allocated to the intervention group were sent the
HRA-O questionnaire. This study examined the effects of
the HRA-O linked with a site-specific reinforcement (i.e.
supplemental counselling by a physician, health educator,
or other health professional) on self reported health
behaviour and use of preventative care. The ethical
approval of the PRO-AGE project was from the Brent Med-
ical Ethics Committee and King's College Hospital
Research Ethics Committee (London), the Ethics Com-
mittee of the Ärztekammer Hamburg (Hamburg) and the
Kantonale Ethikkommission Solothurn (EKO 0023) (Sol-
othurn).
Data collection
Prior to randomisation, all study participants completed a
screening Pra-questionnaire (Probability of repeated
admissions questionnaire) [36], providing information
on selected base-line characteristics of study participants.
Based on this questionnaire, a Pra risk score [36] was cal-
culated to define a priori risk strata in the randomised
controlled study.
Older persons were posted the HRA-O questionnaire and
asked to return the completed questionnaire to their gen-
eral practitioners. For budgetary reasons, no reminders
were sent to older persons who did not return the HRA-O
questionnaire. The HRA-O questionnaire contained the
items listed in Table 1 plus, at the end, a brief survey on
participant feed-back to the questionnaire.
Statistical analyses
Analyses were conducted according to an a priori analytic
plan. Base-line characteristics of persons who returned the
HRA-O questionnaire ("responders") were compared
with those of non-responding persons ("non-respond-
ers") using available pre-randomisation data. P-values for
differences in base-line characteristics were derived from
multivariable logistic regression analyses with a covariate
pool consisting of the individual base-line items. P-values
for differences in the Pra score between responders and
non-responders were derived from t-tests.
Feed-back to the HRA-O questionnaire was compared
between participants with higher and lower educational
level, and between participants older and younger than 75
years. Categorical and binary outcome data are analysed
using Fisher's exact tests, continuous outcome data are
compared using t-tests if normally distributed, Mann-
Whitney U test if skewed. Data were analysed using the
SAS program [37].
Results
Response to HRA-O questionnaire
The numbers (percentage) of persons returning the HRA-
O questionnaire were 1090 (87.9%) in London, 804
(91.6%) in Hamburg, and 748 (85.6%) in Solothurn.
Table 2 compares the characteristics of responders and
non-responders to the HRA-O questionnaire. At all sites,
persons with fair or poor self-perceived health status were
less likely to return the HRA-O questionnaire compared to
persons with good or very good self-perceived health sta-
tus. In Solothurn, this difference was small and statisti-
cally non-significant. In London and Hamburg, this
difference was larger and statistically significant. In Ham-
burg, participant age was also related to HRA-O question-
naire response, with older participants having a lower
return rate as compared to younger participants. No other
characteristics affecting response were identified among
the three sites. Overall Pra risk status was similar between
responders and non-responders.
Feed-back to the HRA-O questionnaire
Acceptance of the HRA-O questionnaire was high, with
more than 85% of persons rating comprehension and
completion of the questionnaire as easy or very easy.
Tables 3 and 4 list the participants' feed-back to the HRA-
O questionnaire according to participants' age and educa-
tional level at the three study sites. As shown in Table 3, a
significantly higher proportion of the over 75-year old
persons had difficulties with the questionnaire, as com-
pared to younger persons. Similarly, persons with a low
level of education had more difficulty comprehending orB
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Table 2: Comparison of responders (persons who returned the Health Risk Appraisal for Older Persons (HRA-O) questionnaire) with non-responders (persons who did not return the 
HRA-O questionnaire) at the three study sites
Baseline characteristics London (U.K.) Hamburg (Germany) Solothurn (Switzerland)
Responders Non-responders P-value Responders Non-responders P-value Responders Non-responders P-value
Age (years) 74.7 ± 6.3 (1090) 74.8 ± 6.7 (150) 0.70 71.5 ± 7.6 (804) 75.5 ± 7.8 (74) 0.002 74.5 ± 5.8 (748) 74.4 ± 6.0 (126) 0.87
Female gender 55.0% (599/1090) 58.0% (87/150) 0.71 60.9% (490/804) 67.6% (50/74) 0.67 56.7% (424/748) 57.9% (73/126) 0.87
Fair/poor self-perceived health 23.1% (252/1090) 34.7% (52/150) 0.004 36.3% (292/804) 63.5% (47/74) <.0001 19.0% (142/748) 25.4% (32/126) 0.10
≥ 1 hospital admission over past 12 months 13.6% (148/1090) 16.7% (25/150) 0.52 21.6% (174/804) 16.2% (12/74) 0.09 20.5% (153/748) 16.7% (21/126) 0.23
> 6 physician visits over past 12 months 20.5% (223/1090) 26.7% (40/150) 0.16 50.1% (403/804) 47.3% (35/74) 0.15 23.3% (174/748) 28.6% (36/126) 0.06
No available caregiver if needed 17.2% (187/1090) 20.7% (31/150) 0.36 16.7% (134/804) 29.7% (22/74) 0.07 10.0% (75/748) 8.7% (11/126) 0.53
Pra score 0.27 ± 0.11 (1090) 0.28 ± 0.12 (150) 0.36 0.30 ± 0.11 (804) 0.30 ± 0.12 (74) 0.71 0.29 ± 0.11 (748) 0.29 ± 0.10 (126) 0.86
Values are percentages (nominator/denominator) or means ± standard deviations (denominator).
P-values based on multivariable logistic regression models with covariate pool consisting of the individual Pra items.
Pra score: Probability of repeated admissions; higher scores denote higher risk for hospital admission and other adverse outcomes. for definition see Methods section.
Table 3: Participants' feedback to the HRA-O questionnaire at the three study sites, according to participants' age
London (U.K.) Hamburg (Germany) Solothurn (Switzerland)
<75 years ≥75 years <75 years ≥75 years <75 years ≥75 years
Comprehension of questions/instructions – % somewhat difficult/very difficult 5.9% (35/598) 11.5% (55/477)** 4.3% (23/535) 6.3% (16/253) 9.2% (38/412) 17.8% (54/304)***
Completion of questionnaire – % somewhat difficult/very difficult 5.9% (35/589) 9.3% (43/464)* 5.0% (25/496) 8.0% (19/237) 7.5% (29/388) 15.8% (44/279)***
Use of assistance for completing questionnaire – % with assistance 8.6% (51/593) 14.6% (69/471)** 5.2% (27/521) 13.1% (32/245)*** 16.4% (67/409) 28.6% (88/308)***
Perceived length of questionnaire – % too long 30.9% (183/593) 35.9% (169/471) 28.2% (148/525) 31.9% (76/238) 54.7% (222/406) 58.4% (180/308)
Time for completion – min. (± SD) 42.6 ± 29.3 (589) 56.2 ± 53.0 (464)*** 58.8 ± 27.7 (518) 67.6 ± 31.4 (235)*** 73.1 ± 39.6 (388) 83.2 ± 48.2 (282)**
Dislike certain sections of questionnaire – % agreeing 4.9% (28/575) 5.9% (27/461) 9.1% (46/507) 6.4% (14/218) 11.8% (44/373) 13.7% (38/277)
Questionnaire should include additional domains – % agreeing 19.5% (112/573) 14.0% (60/429)* 21.0% (102/485) 15.9% (32/201) 5.4% (20/368) 4.5% (12/269)
HRA-O: Health Risk Appraisal for Older Persons
Values are percentages (nominator/denominator) or means ± standard deviations (denominator).
Denominators vary due to missing individual answers.
* denotes .01 <= P < .05; ** denotes .001 <= P < .01; *** denotes P < .001; P-values are based on Fisher's exact test (binary variables) and t-test (continuous variables).BMC Medical Research Methodology 2007, 7:1 http://www.biomedcentral.com/1471-2288/7/1
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answering the questionnaire as compared to persons with
a higher level of education (Table 4). However, even
among subgroups reporting greater difficulty in using the
questionnaire, the proportion of older persons rating the
questionnaire as difficult was less than 20%.
The proportion of persons using assistance for completing
the questionnaire ranged from 5 to 31% percent accord-
ing to subgroup (age or educational level) and study site.
Self-reported time needed for completing the question-
naires varied between study sites and participant age. Per-
sons in Solothurn needed more time to complete the
questionnaire compared to persons in London and Ham-
burg. Those over 75 needed significantly more time to
complete the questionnaire compared to younger persons
in all sites. Many study participants felt the questionnaire
was too long. On the other hand, there was a notable
minority of participants suggesting that additional
domains should be added to the questionnaire.
Prevalence of identified risks and problems
Table 5 lists the prevalence of risks and problems identi-
fied among study participants at the three study sites.
Prevalence rates of identified risks or problems were
between 2 and 91% for the 19 domains covered in the
HRA-O. For some risks there were notable differences in
prevalence rates between sites (e.g., consumption of high
fat food, preventative care use, marginal family ties), indi-
cating that regional factors are associated with risks. Over-
all, at each site the HRA-O questionnaire revealed
relatively high (>10%) prevalence rates of most poten-
tially modifiable risk factors for functional decline.
Self-reported reasons for suboptimal health behaviour and 
preventative care use
Table 6 lists participants' intention to change health
behaviour and self-reported reasons for suboptimal
health behaviour or use of preventative services. With
regard to physical activity (level of physical activity within
the next month or the next 6 months) and nutrition, only
a small minority (5.4 percent or less) declare that they
plan to change food intake within the next month or the
next 6 months. The most frequently reported reason for
not changing level of physical activity and nutrition intake
is the self-perception of optimal health behaviour despite
evidence for suboptimal health behaviour. For example,
In London, among 933 persons with a low level of physi-
cal activity, 338 (36.2%) reported that they did not
increase their level of physical activity because they
thought they already exercised frequently and regularly.
With regard to tobacco use, this was different. One third
to almost one half of persons using tobacco report that
they plan to quit within the next month or the next 6
months.
Table 4: Participants' feedback to the HRA-O questionnaire at the three study sites, according to participants' educational level (low 
vs. medium/high)
London (U.K.) Hamburg (Germany) Solothurn (Switzerland)
low medium/high low medium/high low medium/high
Comprehension of 
questions/instructions – 
% somewhat difficult/very 
difficult
8.9% (57/642) 7.5% (32/426) 7.9% (11/140) 3.8% (23/601) 17.1% (54/316) 8.8% (31/352)**
Completion of 
questionnaire – % 
somewhat difficult/very 
difficult
8.0% (50/626) 6.4% (27/420) 8.5% (11/129) 5.3% (30/563) 15.4% (46/299) 7.0% (23/329)***
Use of assistance for 
completing questionnaire 
– % with assistance
13.1% (83/636) 8.5% (36/423)* 17.6% (24/136) 5.5% (32/583)*** 31.4% (100/318) 14.5% (51/351)***
Perceived length of 
questionnaire – % too 
long
35.7% (227/636) 28.7% (121/421)* 33.3% (46/138) 27.6% (160/580) 60.3% (190/315) 53.0% (186/351)
Time for completion – 
min. (± SD)
51.3 ± 46.2 (627) 44.6 ± 34.6 (419)** 65.0 ± 31.6 (131) 60.8 ± 28.2 (576) 78.9 ± 46.9 (297) 75.5 ± 39.3 (330)
Dislike certain sections of 
questionnaire – % 
agreeing
4.2% (26/612) 6.8% (28/411) 9.7% (12/124) 7.8% (44/563) 11.5% (33/286) 12.9% (41/317)
Questionnaire should 
include additional 
domains – % agreeing
13.4% (79/591) 22.5% (90/400)*** 14.4% (17/118) 20.7% (111/535) 1.8% (5/281) 7.4% (23/311)**
HRA-O: Health Risk Appraisal for Older Persons
Values are percentages (nominator/denominator) or means ± standard deviations (denominator).
Denominators vary due to missing individual answers.
* denotes .01 <= P < .05; ** denotes .001 <= P < .01; *** denotes P < .001; P-values are based on Fisher's exact test (binary variables) and t-test 
(continuous variables).BMC Medical Research Methodology 2007, 7:1 http://www.biomedcentral.com/1471-2288/7/1
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Table 5: Prevalence of risks and problems identified with the HRA-O questionnaire at the three study sites
Domain Definition of problem/risk London (U.K.) Hamburg (Germany) Solothurn (Switzerland)
Accident prevention Driving without using seat belt 16.6% (174/1051) 4.8% (37/765) 12.7% (90/707)
Alcohol use Possible hazardous alcohol use 20.4% (219/1071) 18.8% (133/706) 14.4% (85/591)
Falls History of repeated falls in previous 12 
months
10.6% (111/1048) 7.5% (58/772) 7.2% (50/691)
Self-reported limitation of activities due 
to fear of falling
21.6% (230/1064) 24.1% (189/785) 23.5% (167/711)
Functional status Difficulty in ≥1 BADL item 4.0% (43/1076) 10.4% (82/790) 6.4% (47/730)
Difficulty/need for human assistance in 
≥2 IADL item
16.7% (178/1063) 23.2% (182/785) 19.1% (135/708)
Changed way of doing an activity 51.9% (544/1048) 46.7% (362/775) 51.6% (366/709)
Decreased frequency of activity 36.8% (379/1029) 37.5% (285/760) 37.4% (262/700)
Health status Moderate or fair self-perceived health 
status
22.1% (239/1080) 29.9% (238/796) 15.9% (116/730)
Hearing Impaired hearing 20.7% (206/994) 20.4% (155/759) 28.5% (178/624)
No hearing check-up in previous year 84.6% (908/1073) 63.9% (508/795) 66.2% (473/715)
Incontinence Urinary incontinence on > 5 days during 
the last year
10.7% (111/1042) 27.2% (210/772) 20.6% (144/698)
Medication use Use of ≥4 medications 34.2% (361/1056) 44.3% (332/749) 30.4% (200/657)
Use of long-acting benzodiazepine or 
amitriptyline
5.6% (59/1053) 7.6% (58/768) 7.5% (54/719)
Medication side effect 11.9% (123/1030) 15.1% (114/755) 9.8% (64/652)
Difficulties with medication compliance 9.4% (90/961) 8.0% (53/660) 5.9% (33/564)
Medical History Presence of three or more chronic 
condition(s)
33.4% (354/1059) 52.2% (396/758) 39.5% (279/707)
Memory Memory problems 10.2% (107/1053) 5.2% (41/781) 6.6% (46/701)
Mood Depressive mood 14.3% (155/1085) 24.1% (191/792) 14.4% (105/731)
Nutrition Consumption of >2 high fat food items 
per day
76.1% (788/1035) 35.1% (258/735) 55.7% (354/635)
Consumption of <5 fruit/fibre items per 
day
61.1% (635/1039) 81.2% (608/749) 74.8% (489/654)
Body mass index <20 4.8% (49/1030) 2.3% (18/787) 2.0% (14/709)
Body mass index ≥27 32.9% (339/1030) 41.0% (323/787) 52.9% (375/709)
Loss of weight 3.4% (36/1069) 4.2% (33/795) 4.8% (35/734)
Oral Health Oral health problem 43.9% (463/1054) 28.5% (224/787) 27.1% (188/694)
No dental check in previous year 25.9% (279/1077) 17.4% (139/797) 42.5% (306/720)
Physical activity Less than 5 times/week moderate or 
strenuous activity
90.7% (933/1029) 80.1% (595/743) 88.4% (524/593)
Preventative care No blood pressure check in previous 
year
17.1% (186/1087) 2.5% (20/792) 4.8% (35/734)
Elevated self-reported blood pressure 67.5% (166/246) 61.0% (383/628) 58.4% (261/447)
No mammography in previous 2 years 
(age < 70)
61.0% (94/154) not available 70.6% (72/102)
No cervical smear in previous 3 years 89.7% (525/585) 36.8% (178/484) 60.7% (244/402)
No cholesterol measurement in 
previous 5 years (age < 75)
43.2% (261/604) 6.0% (32/534) 24.9% (99/397)
Elevated self-reported cholesterol (age 
< 75)
8.7% (8/92) 40.3% (94/233) 15.2% (5/33)
No faecal occult blood test in previous 
year (age < 80)
93.0% (796/856) 35.0% (233/665) 68.5% (395/577)
No blood glucose measurement in 
previous 3 years
78.7% (852/1082) 10.8% (85/784) 24.7% (172/695)
No influenza vaccination in previous 
year
18.2% (198/1087) 40.7% (323/794) 53.9% (395/733)
No pneumococcal vaccination (ever) 78.8% (853/1083) 89.7% (703/784) 91.3% (639/700)
Pain Presence of moderate to severe pain 27.9% (291/1044) 37.0% (282/762) 24.9% (166/667)
Social factors Low level of emotional support 10.6% (114/1076) 8.8% (69/784) 9.4% (64/681)
High risk of social isolation 14.1% (152/1076) 19.1% (150/784) 9.7% (66/681)
Marginal family ties 14.4% (155/1076) 18.1% (142/784) 6.6% (45/681)
Marginal friendship ties 17.9% (193/1076) 20.8% (163/784) 18.5% (126/681)
No participation in groups 32.2% (347/1077) 37.9% (301/795) 20.9% (149/713)
Tobacco use Current tobacco use 11.2% (114/1021) 13.1% (97/739) 13.3% (86/645)
Vision Problem in ≥1 vision sub-domain 16.5% (169/1026) 16.2% (125/770) 13.7% (93/681)
No vision check-up in previous year 34.1% (369/1081) 28.3% (225/795) 38.3% (280/732)
HRA-O: Health Risk Appraisal for Older Persons
Values are percentages (nominator/denominator).
Denominators vary due to missing individual answers.
For definition of variables, see Table 1.BMC Medical Research Methodology 2007, 7:1 http://www.biomedcentral.com/1471-2288/7/1
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Table 6: Intention to change health behaviour and self-reported reasons for not changing health behaviour/preventative care use 
identified with the HRA-O questionnaire at the three study sites
Category Self reported answer 
category
London (U.K.) Hamburg (Germany) Solothurn 
(Switzerland)
Intention to increase 
physical activity
Plans to take steps in next 
month
2.5% (21/853) 1.0% (5/507) 1.6% (7/426)
Plans to take steps in the 
next 6 months
2.9% (25/853) 0.6% (3/507) 0.2% (1/426)
Reasons for not increasing 
physical acitivity
I already exercise 
frequently and regularly
36.2% (338/933) 47.7% (284/595) 63.2% (331/524)
I have a physical limitation 22.0% (205/933) 14.3% (85/595) 6.7% (35/524)
I don't have time/don't get 
around it
18.8% (175/933) 6.1% (36/595) 3.8% (20/524)
I have pain with physical 
activity
18.0% (168/933) 25.7% (153/595) 16.8% (88/524)
I have an illness limiting my 
physical activity
11.5% (107/933) 25.9% (154/595) 13.2% (69/524)
I don't have anyone to 
exercise with
5.8% (54/933) 8.4% (50/595) 4.4% (23/524)
There is nowhere to 
exercise
1.9% (18/933) 8.7% (52/595) 4.8% (25/524)
Intention to decrease high 
fat intake
Plans to take steps in next 
month
2.1% (16/765) 2.8% (7/253) 0.9% (3/333)
Plans to take steps in the 
next 6 months
1.6% (12/765) 0.8% (2/253) 0.9% (3/333)
Reason for not decreasing 
high fat intake
I already minimise fat 
intake
75.4% (594/788) 70.9% (183/258) 67.5% (239/354)
I like the taste of high-fat 
foods
19.5% (154/788) 19.4% (50/258) 9.3% (33/354)
I don't think it's important 
to eat less fat
5.3% (42/788) 11.6% (30/258) 13.6% (48/354)
Trouble to shop/prepare 
low-fat foods
2.4% (19/788) 5.4% (14/258) 7.6% (27/354)
Intention to increase fruit/
fibre intake
Plans to take steps in next 
month
0.8% (5/623) 0.7% (4/596) 0.2% (1/470)
Plans to take steps in the 
next 6 months
1.0% (6/623) 0.2% (1/596) 0.2% (1/470)
Reason for not increasing 
low fruit/fibre intake
I already eat plenty of 
fruits/vegetables
87.9% (558/635) 91.0% (553/608) 93.7% (458/489)
Intention to change current 
tobacco use
Plans to quit smoking in 
next month
16.7% (14/84) 16.0% (12/75) 22.6% (12/53)
Plans to quit smoking in 
next 6 months
28.6% (24/84) 17.3% (13/75) 18.9% (10/53)
Reason for not using 
preventative services
My general practitioner 
never recommended it
50.5% (548/1086) 22.2% (173/778) 16.0% (117/731)
I've never thought about it 21.5% (234/1086) 12.3% (96/778) 10.9% (80/731)
I have no need to; I have no 
health problems
17.5% (190/1086) 17.0% (132/778) 20.2% (148/731)
I have already had these 
preventative services
15.7% (171/1086) 37.1% (289/778) 39.8% (291/731)
HRA-O: Health Risk Appraisal for Older Persons, values are percentages (nominator/denominator).
Denominators are persons at risk for the selected health behaviour or preventative care use (e.g., intention to decrease high fat intake among 
persons with high fat intake, as defined in Table 5). Answers are for predefined categories. Multiple answer were allowed for reasons of sub-optimal 
health behaviour; only reasons given by ≥5% of persons in at least one study site are listed, and listed according to the rank order in London.BMC Medical Research Methodology 2007, 7:1 http://www.biomedcentral.com/1471-2288/7/1
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The self-reported reasons for not using all preventative
care services recommended to older persons varied by site.
In London, more than 50% of the participants stated that
their general practitioner had never recommended it. In
Solothurn and Hamburg, the most frequently given rea-
son was "I have already had these preventative services."
Other reasons, such as cost or lack of time were given by
less than 5 percent of participants at all sites.
Discussion
To our knowledge this is the first HRA instrument for use
in older persons that has been developed and evaluated
outside North America for international use. Base-line
data from its use in the PRO-AGE multi-centre trial con-
firm that the HRA-O questionnaire is feasible in this pop-
ulation, including those at advanced age and with lower
educational levels. In addition, the HRA-O questionnaire
identifies a large number of potentially modifiable risks
for functional decline and related problems. Participants'
intention to change, and self-reported reasons for not
changing health behaviour suggested that for some risk
factors participants were in a pre-contemplation phase
[27], having no short- or medium-term plans for changing
health behaviour, and many perceived their health behav-
iour or preventative care uptake as optimal, despite indi-
cations of deficits according to the HRA-O based
evaluation.
There are some limitations. This study might overestimate
the response rate to the HRA-O questionnaire because
only those participants who had given informed consent
to participate in the study were sent the HRA-O question-
naire. This limitation cannot be avoided in the context of
a controlled trial. Despite this limitation, the response
rate of >80% for a multidimensional questionnaire, with-
out a reminder system, is remarkable and underlines its
practicability. One likely explanation of the high response
rate was the contribution of the general practitioner's rela-
tionship with his/her patients.
Second, although acceptability of the instrument would
certainly differ in populations with a very low level of edu-
cation (in this project, most persons classified as having a
low level of education had had 9 years of education), it is
likely that the instrument can be used at other sites as well.
The three study sites represented here include urban and
rural regions, different languages, different health care sys-
tems, and persons with a broad range of socioeconomic
characteristics.
Third, the prevalence rates found in this study may not be
representative of the population of community-dwelling
older persons in these regions. Participants were selected
according to practice registration and eligibility criteria,
and persons not interested in participating in the study
were excluded. Nevertheless, comparison of participant
characteristics with available national data reveals similar-
ities, suggesting that findings of this study give appropri-
ate estimates for non-disabled non-institutionalised older
persons.
Conclusion
This study has implications for practice and research.
HRA-O has multiple advantages, compared with other
HRA tools for older persons. For one, the present HRA-O
shares the distinguishing features of HRA-E, as described
earlier. In addition, this study gave evidence that HRA-O
has additional unique benefits: HRA-O has high accept-
ance rates and good feasibility in community-dwelling
older persons at different sites, and HRA-O has proven to
be functional in a multilingual mode.
At the present time, many intervention programs address-
ing health promotion and prevention have used alterna-
tive strategies requiring a large amount of professional
time without a self-administered component. For exam-
ple, most programs of preventive home visits start with an
approximately two-hour multidimensional evaluation of
older persons by a health professional [38]. Other pro-
grams use a self-administered survey approach, but are
limited to a brief questionnaire focussing on general
aspects of health risks and do not address all potential risk
domains with domain-specific screening instruments [1].
There is potential for further development. First, with
additional data and analyses from the PRO-AGE study, a
further update of the HRA-O is currently under way. Sec-
ond, in the UK, the Department of Health is currently
funding a study to identify social aspects that could be
added to HRA-O [39]. Third, in the future, it might be pos-
sible to give quantitative estimates of individual risks for
functional decline, and the potential impact of risk factor
modification. The HRA-O instrument combined with spe-
cific interventions might be a promising tool for individ-
ualised health promotion and prevention programs in
older persons.
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